These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20400859)

  • 1. Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?
    Brezski RJ; Jordan RE
    MAbs; 2010; 2(3):212-20. PubMed ID: 20400859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated and microbial proteases compromise host IgG effector functions by a single cleavage proximal to the hinge.
    Brezski RJ; Vafa O; Petrone D; Tam SH; Powers G; Ryan MH; Luongo JL; Oberholtzer A; Knight DM; Jordan RE
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17864-9. PubMed ID: 19815504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge.
    Brezski RJ; Oberholtzer A; Strake B; Jordan RE
    MAbs; 2011; 3(6):558-67. PubMed ID: 22123056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic single hinge cleavage of pertuzumab impairs its Fc effector function and antitumor activity in vitro and in vivo.
    Hsiao HC; Fan X; Jordan RE; Zhang N; An Z
    Breast Cancer Res; 2018 Jun; 20(1):43. PubMed ID: 29859099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptide immunization approach to counteract a Staphylococcus aureus protease defense against host immunity.
    Jordan RE; Fernandez J; Brezski RJ; Greenplate AR; Knight DM; Raju TS; Lynch AS
    Immunol Lett; 2016 Apr; 172():29-39. PubMed ID: 26905931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human anti-IgG1 hinge autoantibodies reconstitute the effector functions of proteolytically inactivated IgGs.
    Brezski RJ; Luongo JL; Petrone D; Ryan MH; Zhong D; Tam SH; Schmidt AP; Kruszynski M; Whitaker BP; Knight DM; Jordan RE
    J Immunol; 2008 Sep; 181(5):3183-92. PubMed ID: 18713989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass.
    Deveuve Q; Lajoie L; Barrault B; Thibault G
    Front Immunol; 2020; 11():168. PubMed ID: 32117299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The origins, specificity, and potential biological relevance of human anti-IgG hinge autoantibodies.
    Brezski RJ; Knight DM; Jordan RE
    ScientificWorldJournal; 2011 May; 11():1153-67. PubMed ID: 21623461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The hinge region of therapeutic antibodies: major importance of a short sequence].
    Deveuve Q; Gouilleux-Gruart V; Thibault G; Lajoie L
    Med Sci (Paris); 2019 Dec; 35(12):1098-1105. PubMed ID: 31903923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins and their receptors, and subversion of their protective roles by bacterial pathogens.
    Woof JM
    Biochem Soc Trans; 2016 Dec; 44(6):1651-1658. PubMed ID: 27913674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid.
    Ryan MH; Petrone D; Nemeth JF; Barnathan E; Björck L; Jordan RE
    Mol Immunol; 2008 Apr; 45(7):1837-46. PubMed ID: 18157932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel therapeutic strategy to rescue the immune effector function of proteolytically inactivated cancer therapeutic antibodies.
    Fan X; Brezski RJ; Deng H; Dhupkar PM; Shi Y; Gonzalez A; Zhang S; Rycyzyn M; Strohl WR; Jordan RE; Zhang N; An Z
    Mol Cancer Ther; 2015 Mar; 14(3):681-91. PubMed ID: 25552368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunctional Antibodies in the Tumor Microenvironment Associate with Impaired Anticancer Immunity.
    Zhang N; Deng H; Fan X; Gonzalez A; Zhang S; Brezski RJ; Choi BK; Rycyzyn M; Strohl W; Jordan R; An Z
    Clin Cancer Res; 2015 Dec; 21(23):5380-90. PubMed ID: 26224871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells.
    Huang T; Mathieu M; Lee S; Wang X; Kee YS; Bevers JJ; Ciferri C; Estavez A; Wong M; Chiang NY; Nakamura G; Brezski RJ
    J Biol Chem; 2018 Jan; 293(3):906-919. PubMed ID: 29191832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence of ovine Ig gamma 2 constant region heavy chain cDNA and molecular modelling of ruminant IgG isotypes.
    Clarkson CA; Beale D; Coadwell JW; Symons DB
    Mol Immunol; 1993 Sep; 30(13):1195-204. PubMed ID: 8413324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evading pre-existing anti-hinge antibody binding by hinge engineering.
    Kim HS; Kim I; Zheng L; Vernes JM; Meng YG; Spiess C
    MAbs; 2016; 8(8):1536-1547. PubMed ID: 27606571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deficient cleavage of M protein-bound IgG by IdeS: insight into the escape of Streptococcus pyogenes from antibody-mediated immunity.
    Su YF; Chuang WJ; Wang SM; Chen WY; Chiang-Ni C; Lin YS; Wu JJ; Liu CC
    Mol Immunol; 2011 Oct; 49(1-2):134-42. PubMed ID: 21925735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro functional characterization of feline IgGs.
    Strietzel CJ; Bergeron LM; Oliphant T; Mutchler VT; Choromanski LJ; Bainbridge G
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):214-23. PubMed ID: 24560097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered protease-resistant antibodies with selectable cell-killing functions.
    Kinder M; Greenplate AR; Grugan KD; Soring KL; Heeringa KA; McCarthy SG; Bannish G; Perpetua M; Lynch F; Jordan RE; Strohl WR; Brezski RJ
    J Biol Chem; 2013 Oct; 288(43):30843-54. PubMed ID: 23986451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.